1. Home
  2. CLYM vs NA Comparison

CLYM vs NA Comparison

Compare CLYM & NA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CLYM
  • NA
  • Stock Information
  • Founded
  • CLYM 2018
  • NA 2019
  • Country
  • CLYM United States
  • NA China
  • Employees
  • CLYM N/A
  • NA N/A
  • Industry
  • CLYM
  • NA Semiconductors
  • Sector
  • CLYM
  • NA Technology
  • Exchange
  • CLYM NYSE
  • NA Nasdaq
  • Market Cap
  • CLYM 101.6M
  • NA 109.1M
  • IPO Year
  • CLYM 2021
  • NA 2022
  • Fundamental
  • Price
  • CLYM $1.47
  • NA $6.58
  • Analyst Decision
  • CLYM
  • NA
  • Analyst Count
  • CLYM 0
  • NA 0
  • Target Price
  • CLYM N/A
  • NA N/A
  • AVG Volume (30 Days)
  • CLYM 331.6K
  • NA 66.9K
  • Earning Date
  • CLYM 03-27-2025
  • NA 03-17-2025
  • Dividend Yield
  • CLYM N/A
  • NA N/A
  • EPS Growth
  • CLYM N/A
  • NA N/A
  • EPS
  • CLYM N/A
  • NA N/A
  • Revenue
  • CLYM N/A
  • NA $6,991,446.00
  • Revenue This Year
  • CLYM N/A
  • NA N/A
  • Revenue Next Year
  • CLYM N/A
  • NA N/A
  • P/E Ratio
  • CLYM N/A
  • NA N/A
  • Revenue Growth
  • CLYM N/A
  • NA N/A
  • 52 Week Low
  • CLYM $1.41
  • NA $2.75
  • 52 Week High
  • CLYM $11.55
  • NA $23.50
  • Technical
  • Relative Strength Index (RSI)
  • CLYM N/A
  • NA 44.56
  • Support Level
  • CLYM N/A
  • NA $6.30
  • Resistance Level
  • CLYM N/A
  • NA $7.24
  • Average True Range (ATR)
  • CLYM 0.00
  • NA 0.50
  • MACD
  • CLYM 0.00
  • NA 0.02
  • Stochastic Oscillator
  • CLYM 0.00
  • NA 41.96

About CLYM CLIMB BIO INC

Climb Bio Inc is a clinical-stage biotechnology company developing therapeutics for patients with immune-mediated diseases. its lead product candidate, budoprutug, is an anti-CD19 monoclonal antibody that has demonstrated B-cell depletion and has the potential to treat a broad range of B-cell-mediated diseases.

About NA Nano Labs Ltd

Nano Labs Ltd operates as a fabless IC design company and product solution provider in China. It engages in the development of HTC chips, HPC chips, distributed computing and storage solutions, smart-NICs, vision computing chips, and distributed rendering. Its products comprise Cuckoo 1.0 Chip, Cuckoo 2.0 Chip, and Darkbird 1.0 Chip. Majority of the company revenue comes from China.

Share on Social Networks: